Trxade Health Inc.
13F holders, Q2 2024 (June 30)6holders −3
1new positions
4sold out
1famous investor
$11.16avg. 13F price*
At the end of Q2 2024, 6 institutions reported holding Trxade Health Inc. in their 13F filings, down 3 from Q1 2024. 1 opened new positions and 4 sold out. The largest holders were Vanguard Group Inc. ($163K), Renaissance Technologies ($131K) and BlackRock Inc. ($92K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Trxade Health Inc.
- CUSIP
- 89846A405
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $78 |
| Exits | 4 | $216K |
All 13F filers, Q1 2024 → Q2 2024: 7 shares bought and 43,148 shares sold, net −43,141 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Vanguard Group Inc. | 0.00% | No change | 14,548 | $163K |
| Renaissance Technologies | 0.00% | Reduce -65.0% | 11,700 | $131K |
| BlackRock Inc. | 0.00% | No change | 8,220 | $92K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -39.0% | 622 | $7K |
| Blue Trust, Inc. | 0.00% | No change | 357 | $4K |
| Bank of America Corp. | 0.00% | New | 7 | $78 |
"% of holder's portfolio" is TRXADE HEALTH INC's weight in each manager's 13F, not the share of Trxade Health Inc. the manager owns.